International Stroke Conference 2025  /  Advances and Controversies in Pediatric Moyamoya Disease  /  Non-surgical Treatment of Moyamoya Disease, Conventional and Emerging
Logo

American Heart Association

  123
  0

Final ID:

Non-surgical Treatment of Moyamoya Disease, Conventional and Emerging

  • Bang, Oh Young  ( Samsung Medical Center , Seoul , Korea (the Republic of) )
    • Author Disclosures:
    Oh Young Bang: DO have relevant financial relationships ; Employee:S&E bio, CO, Inc.:Active (exists now)
Meeting Info:

International Stroke Conference 2025

2025

Los Angeles, CA

Session Info:

Advances and Controversies in Pediatric Moyamoya Disease

Wednesday, 02/05/2025 , 07:30AM - 09:00AM

ISC Invited Symposium

More abstracts on this topic:
Genetic Diversity of Moyamoya

Hausman Kedem Moran, Dlamini Nomazulu

Controversies in Treatment of Moyamoya in Sickle Cell Disease

Aldana Philipp, Gutierrez-aguirre Salvador

More abstracts from these authors:
Clinical scale MSC-derived extracellular vesicles enhance poststroke neuroplasticity in a non-human primate model of stroke

Bang Oh Young, Son Jeong Pyo, Kim Eun Hee, Chopp Michael

MMA Emerging as a Widespread Systemic Disease

Bang Oh Young

You have to be authorized to contact abstract author. Please, Login
Not Available

Readers' Comments

We encourage you to enter the discussion by posting your comments and questions below.

Presenters will be notified of your post so that they can respond as appropriate.

This discussion platform is provided to foster engagement, and simulate conversation and knowledge sharing.

 

You have to be authorized to post a comment. Please, Login or Signup.

   Rate this abstract  (Maximum characters: 500)